» Articles » PMID: 9430633

Activation of Phospholipase C Gamma by PI 3-kinase-induced PH Domain-mediated Membrane Targeting

Overview
Journal EMBO J
Date 1998 Feb 28
PMID 9430633
Citations 164
Authors
Affiliations
Soon will be listed here.
Abstract

Signaling via growth factor receptors frequently results in the concomitant activation of phospholipase C gamma (PLC gamma) and phosphatidylinositol (PI) 3-kinase. While it is well established that tyrosine phosphorylation of PLC gamma is necessary for its activation, we show here that PLC gamma is regulated additionally by the lipid products of PI 3-kinase. We demonstrate that the pleckstrin homology (PH) domain of PLC gamma binds to phosphatidylinositol 3,4,5-trisphosphate [PdtIns(3,4,5)P3], and is targeted to the membrane in response to growth factor stimulation, while a mutated version of this PH domain that does not bind PdtIns(3,4,5)P3 is not membrane targeted. Consistent with these observations, activation of PI 3-kinase causes PLC gamma PH domain-mediated membrane targeting and PLC gamma activation. By contrast, either the inhibition of PI 3-kinase by overexpression of a dominant-negative mutant or the prevention of PLC gamma membrane targeting by overexpression of the PLC gamma PH domain prevents growth factor-induced PLC gamma activation. These experiments reveal a novel mechanism for cross-talk and mutual regulation of activity between two enzymes that participate in the control of phosphoinositide metabolism.

Citing Articles

MAPK4 inhibits the early aberrant activation of B cells in rheumatoid arthritis by promoting the IRF4-SHIP1 signaling pathway.

Huang P, Yang G, Zhang P, Zhu Y, Guan Y, Sun J Cell Death Dis. 2025; 16(1):43.

PMID: 39863600 PMC: 11763251. DOI: 10.1038/s41419-025-07352-2.


Hyperactive PLCG1 drives non-canonical signaling to promote cell survival.

Zeng L, Zhang X, Xiong Y, Sato K, Hajicek N, Sondek J bioRxiv. 2025; .

PMID: 39763946 PMC: 11702640. DOI: 10.1101/2024.12.17.628879.


Astragaloside IV protects brain cells from ischemia-reperfusion injury by inhibiting ryanodine receptor expression and reducing the expression of P-Src and P-GRK2.

Chen J, Bao J, Jiang X, Yu W, Han Y, Zhang X Sci Rep. 2024; 14(1):17497.

PMID: 39080440 PMC: 11289356. DOI: 10.1038/s41598-024-68462-z.


Signal Transduction of Transient Receptor Potential TRPM8 Channels: Role of PIP5K, Gq-Proteins, and c-Jun.

Thiel G, Rossler O Molecules. 2024; 29(11).

PMID: 38893478 PMC: 11174004. DOI: 10.3390/molecules29112602.


The ion channel TRPV5 regulates B-cell signaling and activation.

Mahtani T, Sheth H, Smith L, Benedict L, Brecier A, Ghasemlou N Front Immunol. 2024; 15:1386719.

PMID: 38694510 PMC: 11061418. DOI: 10.3389/fimmu.2024.1386719.


References
1.
Falasca M, Carvelli A, Iurisci C, Qiu R, Symons M, Corda D . Fast receptor-induced formation of glycerophosphoinositol-4-phosphate, a putative novel intracellular messenger in the Ras pathway. Mol Biol Cell. 1997; 8(3):443-53. PMC: 276096. DOI: 10.1091/mbc.8.3.443. View

2.
Rhee S, Bae Y . Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem. 1997; 272(24):15045-8. DOI: 10.1074/jbc.272.24.15045. View

3.
Kojima T, Fukuda M, Watanabe Y, Hamazato F, Mikoshiba K . Characterization of the pleckstrin homology domain of Btk as an inositol polyphosphate and phosphoinositide binding domain. Biochem Biophys Res Commun. 1997; 236(2):333-9. DOI: 10.1006/bbrc.1997.6947. View

4.
Logan S, Falasca M, Hu P, Schlessinger J . Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway. Mol Cell Biol. 1997; 17(10):5784-90. PMC: 232426. DOI: 10.1128/MCB.17.10.5784. View

5.
Cifuentes M, Delaney T, Rebecchi M . D-myo-inositol 1,4,5-trisphosphate inhibits binding of phospholipase C-delta 1 to bilayer membranes. J Biol Chem. 1994; 269(3):1945-8. View